Stay updated on Azacitidine and Pembrolizumab in Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the Azacitidine and Pembrolizumab in Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Azacitidine and Pembrolizumab in Pancreatic Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The footer now identifies the site as revision v3.8.0 instead of v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-31T13:57:00.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    A banner announces NIH’s website transition and says federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-24T13:21:24.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The site’s footer revision indicator changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T13:26:31.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T13:17:25.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The study page now returns a 403 Forbidden error, indicating restricted access, instead of displaying the study record content.
    Difference
    18%
    Check dated 2026-09-19T14:11:29.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    A new page revision v3.6.6 was added and the previous revision v3.6.5 was removed, indicating a small update to the page's revision history.
    Difference
    0.1%
    Check dated 2026-08-29T14:09:05.000Z thumbnail image

Stay in the know with updates to Azacitidine and Pembrolizumab in Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Azacitidine and Pembrolizumab in Pancreatic Cancer Clinical Trial page.